Related Experiment Videos
[Diagnostic evaluation on cerebral hemisphere scintigraphy using 99mTc-MAA (author's transl)]
Summary
This study used technetium-99m-labeled macroaggregated albumin (99mTc-MAA) to map cerebral blood flow in 151 patients. The technique effectively identifies cerebral infarcts and other cerebrovascular abnormalities with reduced radiation exposure.
Area of Science:
- Nuclear Medicine
- Neurology
- Radiology
Background:
- Cerebrovascular diseases pose significant diagnostic challenges.
- Accurate assessment of cerebral blood flow is crucial for diagnosis and treatment planning.
Purpose of the Study:
- To evaluate the utility of 99mTc-MAA for assessing cerebral blood flow distribution in various cerebrovascular diseases.
- To determine the sensitivity of 99mTc-MAA in detecting cerebral infarcts and other lesions.
Main Methods:
- 151 patients with various cerebrovascular diseases underwent cerebral blood flow imaging.
- 3 mCi of 99mTc-MAA (particle size 10-100 micron) was injected into the common carotid artery.
- Cerebral blood flow distribution was analyzed based on 99mTc-MAA uptake patterns.
Main Results:
- 99mTc-MAA distribution was homogeneous in normal cerebral hemispheres but heterogeneous in diseased areas.
- Lesions typically appeared as non-radioactive areas, while hypervascular meningiomas appeared as hot areas.
- Cerebral infarcts, even in small arteries, were clearly visualized, surpassing conventional angiography (CAG) detection capabilities.
Conclusions:
- 99mTc-MAA scintigraphy is a valuable, sensitive tool for detecting cerebral infarcts and other cerebrovascular abnormalities.
- The method offers reduced radiation exposure compared to standard brain scans due to lower dosage and rapid excretion.
- This technique aids in the diagnosis of cerebral infarcts, sequelae of cerebral apoplexy, and head injuries.